Ontology highlight
ABSTRACT:
SUBMITTER: Harvey RD
PROVIDER: S-EPMC6256010 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
Harvey R Donald RD Aransay Noemi Reguart NR Isambert Nicolas N Lee Jong-Seok JS Arkenau Tobias T Vansteenkiste Johan J Dickinson Paul A PA Bui Khanh K Weilert Doris D So Karen K Thomas Karen K Vishwanathan Karthick K
British journal of clinical pharmacology 20181010 12
<h4>Aim</h4>We report on two Phase 1, open-label, single-arm studies assessing the effect of osimertinib on simvastatin (CYP3A substrate) and rosuvastatin (breast cancer resistance protein substrate [BCRP] substrate) exposure in patients with advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer who have progressed after treatment with an EGFR tyrosine kinase inhibitor, to determine, upon coadministration, whether osimertinib could affect the exposure of these agent ...[more]